Literature DB >> 32577538

Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI).

Margaret Wiggins1, Franchesca Arias1,2,3, Richard D Urman4, Deborah C Richman5, Bobbie Jean Sweitzer6, Angela F Edwards7, Melissa J Armstrong8,9, Anita Chopra10, David J Libon10, Catherine Price1,3,11.   

Abstract

Aging is associated with normal and abnormal brain and cognitive changes. Due to the expected increase in older adults requiring surgery, perioperative clinicians will be increasingly encountering patients with neurodegenerative disease. To help perioperative clinicians understand signs of abnormal behaviors that may mark an undiagnosed neurodegenerative disorder and alert additional patient monitoring, The Society for Perioperative Assessment and Quality Improvement (SPAQI) worked with experts in dementia, neuropsychology, geriatric medicine, neurology, and anesthesiology to provide a summary of cognitive and behavioral considerations for patients with common neurodegenerative disorders being evaluated at preoperative centers. Patients with neurodegenerative disorders are at high risk for delirium due to known neurochemical disruptions, medication interactions, associated frailty, or vascular risk profiles presenting risk for repeat strokes. We provide basic information on the expected cognitive changes with aging, most common neurodegenerative disorders, a list of behavioral features and considerations to help differentiate neurodegenerative disorders. Finally, we propose screening recommendations intended for a multidisciplinary team in the perioperative setting.

Entities:  

Keywords:  dementias; neurodegenerative syndromes; perioperative care

Year:  2020        PMID: 32577538      PMCID: PMC7311090          DOI: 10.1016/j.pcorm.2020.100092

Source DB:  PubMed          Journal:  Perioper Care Oper Room Manag        ISSN: 2405-6030


  75 in total

1.  Type and severity of cognitive decline in older adults after noncardiac surgery.

Authors:  Catherine C Price; Cynthia W Garvan; Terri G Monk
Journal:  Anesthesiology       Date:  2008-01       Impact factor: 7.892

2.  Regional leukoaraiosis and cognition in non-demented older adults.

Authors:  Margaret E Wiggins; Jared Tanner; Nadine Schwab; Samuel J Crowley; Ilona Schmalfuss; Babette Brumback; David J Libon; Kenneth Heilman; Catherine C Price
Journal:  Brain Imaging Behav       Date:  2019-10       Impact factor: 3.978

3.  Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein.

Authors:  T Arai; K Uéda; K Ikeda; H Akiyama; C Haga; H Kondo; N Kuroki; K Niizato; S Iritani; K Tsuchiya
Journal:  Neurosci Lett       Date:  1999-01-08       Impact factor: 3.046

4.  Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.

Authors:  Dilman Sadiq; Tim Whitfield; Lean Lee; Tim Stevens; Sergi Costafreda; Zuzana Walker
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Multi-infarct dementia.

Authors:  V Hachinski
Journal:  Neurol Clin       Date:  1983-02       Impact factor: 3.806

7.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

Review 9.  Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease.

Authors:  Alan King Lun Liu; Raymond Chuen-Chung Chang; Ronald K B Pearce; Steve M Gentleman
Journal:  Acta Neuropathol       Date:  2015-01-30       Impact factor: 17.088

10.  Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-10-01       Impact factor: 44.182

View more
  1 in total

Review 1.  The New Frontier of Perioperative Cognitive Medicine for Alzheimer's Disease and Related Dementias.

Authors:  Catherine C Price
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.